MGMarcus Gertzen

Marcus Gertzen

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Marcus Gertzen has a total of 38 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Smoking Topography, Nicotine Kinetics, and Subjective Smoking Experience of Mentholated and Non-Mentholated Heated Tobacco Products in Occasional Smokers

    by Benedikt Rieder, Yvonne Stoll, Christin Falarowski, Marcus Gertzen, Gabriel Kise, Gabriele Koller, Sarah Koch, Peter Laux, Andreas Luch, Anna Rahofer, et al.

    Background: Heated tobacco products (HTPs) are marketed as reduced-harm alternatives to conventional cigarettes (CCs) and are increasingly used by young adults and occasional smokers. However, their acute nicotine delivery and user experience remain insufficiently studied in occasional smokers without established cigarette or nicotine dependence. Additives such as menthol—known to reduce sensory irritation and facilitate inhalation—may further influence initiation and product appeal, particularly in naïve users. Methods: In a crossover study with three separate study days, n = 15 occasional smokers without established cigarette or nicotine dependence consumed a mentholated HTP (mHTP), a non-mentholated HTP (nmHTP), and a conventional cigarette (CC) under ad libitum conditions during a 30 min observation. We measured plasma nicotine concentrations, smoking topography, cardiovascular parameters, and subjective effects (mCEQ). Results: Nicotine pharmacokinetics (Cmax, AUC) were comparable across products (Cmax 7.8–8.5 ng/mL; AUC 2.3–2.8 ng·min/mL [geometric means]; no significant differences), even though participants had no prior experience with HTPs. Compared to CCs, HTPs were associated with longer puff durations (2.09 s mHTP/2.00 s nmHTP vs. 1.78 s CC), higher puff volumes (mean: 68.06/68.16 vs. 43.76 mL; total: 949.80/897.73 vs. 522.41 mL), and greater flow rates (mean 37.49/38.25 vs. 27.68 mL/s; peak 63.24/63.69 vs. 44.38 mL/s). Subjective effects did not differ significantly between products (mCEQ subscale examples: satisfaction 3.00–3.33/7; reward 2.81–3.31/7; craving reduction 5.07–5.60/7). Cardiovascular parameters such as heart rate or systolic blood pressure showed with no between-product differences (HR p = 0.518; SBP p = 0.109) and no differences in their change over time between products (HR p = 0.807; SBP p = 0.734). No differences were observed between mHTP and nmHTP. Conclusion: HTPs can deliver nicotine and evoke user experiences similar to CCs, even in non-dependent users. The more intensive inhalation behavior observed with HTPs may reflect compensatory use and merits further investigation. Although no menthol-specific effects were observed, methodological constraints may have limited their detectability.

  • Open Access

    “I Can’t Get No Satisfaction”—Psychosocial Aspects and Awareness of Negative Impacts in Chemsex Users: Results from an Anonymous Online Survey

    by Marcus Gertzen, Sinan Karcher, Johanna Schwarz, Cornelia Rosenberger, Moritz Strasburger, Andrea Rabenstein, Anna-Martina Strasser, Ulrich Palm, Tobias Rüther

    Chemsex is the interplay of substance use by men who have sex with men (MSM) in sexual contexts. The minority stress model and the identity process theory are explanatory models. In this study, we investigated whether (i) differences in certain psychosocial aspects (i.e., shame, aspects of queer identity, and sexual self-concepts) exist between chemsex users and non-users, and (ii) which factors influence an awareness of negative impacts in chemsex users. We conducted an anonymous, cross-sectional, online survey, including sociodemography, sexual history, history of substance use, validated scales for shame-proneness, aspects of queer identity, and sexual self-concepts. Our analysis comprised descriptive statistics, t-tests, Spearman’s correlations, and a multiple linear regression model. We recorded a total of 3257 datasets with 107 chemsex users. Chemsex users showed higher rates for risky sexual behavior. Values for shame proneness, more negative aspects of queer identity, and sexual self-concepts were elevated in chemsex users with an awareness of negative impacts. Sexual anxiety, intravenous substance use, and having had a difficult process coming out were significant predictors of feeling negative impacts. Aspects of shame, queer identity aspects, and sexual self-concepts play an important role in the field of chemsex. Different explanatory models seem to be relevant for different subgroups of chemsex users. Chemsex users with an awareness of a problem were particularly vulnerable and distressed but had the highest motivation for change. Prevention, counseling, and care might profit from the inclusion of these aspects. Further anti-stigma campaigns and a specialization of the healthcare system are needed. Registration: DRKS00022336, date: 29th of October, 2020.


  • Open Access

    Glutaryl-CoA Dehydrogenase Misfolding in Glutaric Acidemia Type 1

    by Madalena Barroso, Marcus Gertzen, Alexandra F. Puchwein-Schwepcke, Heike Preisler, Andreas Sturm, Dunja D. Reiss, Marta K. Danecka, Ania C. Muntau, Søren W. Gersting

    Glutaric acidemia type 1 (GA1) is a neurotoxic metabolic disorder due to glutaryl-CoA dehydrogenase (GCDH) deficiency. The high number of missense variants associated with the disease and their impact on GCDH activity suggest that disturbed protein conformation can affect the biochemical phenotype. We aimed to elucidate the molecular basis of protein loss of function in GA1 by performing a parallel analysis in a large panel of GCDH missense variants using different biochemical and biophysical methodologies. Thirteen GCDH variants were investigated in regard to protein stability, hydrophobicity, oligomerization, aggregation, and activity. An altered oligomerization, loss of protein stability and solubility, as well as an augmented susceptibility to aggregation were observed. GA1 variants led to a loss of enzymatic activity, particularly when present at the N-terminal domain. The reduced cellular activity was associated with loss of tetramerization. Our results also suggest a correlation between variant sequence location and cellular protein stability (p < 0.05), with a more pronounced loss of protein observed with variant proximity to the N-terminus. The broad panel of variant-mediated conformational changes of the GCDH protein supports the classification of GA1 as a protein-misfolding disorder. This work supports research toward new therapeutic strategies that target this molecular disease phenotype.


  • Chemsex

    by Marcus Gertzen, Moritz Strasburger, Jan Geiger, Cornelia Rosenberger, Solveig Gernun, Johanna Schwarz, Andrea Rabenstein, Tobias Rüther

    Zusammenfassung Hintergrund Innerhalb der letzten Jahre zeigten sich Hinweise für die Zunahme des Phänomens „Chemsex“, eine Unterform des sexualisierten Substanzgebrauchs. Bei Chemsex handelt es sich um einen Neologismus aus den beiden Begriffen „chemicals“ und „sex“. Er beschreibt den Konsum von Methamphetamin, γ‑Hydroxybuttersäure/γ-Butyrolacton (GHB/GBL), Mephedron und teils weiteren Substanzen zur Beeinflussung sexueller Aktivität, vor allem durch Männer, die Sex mit Männern haben (MSM), und wird als bedeutender Risikofaktor für psychische und körperliche Erkrankungen beschrieben Ziel der Arbeit Aufgrund der zunehmenden Bedeutung des Phänomens und der somit deutlich gestiegenen Zahl an Publikationen zur Thematik, ist das Ziel dieser Arbeit, eine Übersicht über die aktuelle und relevante Literatur zu geben. Hierdurch soll mehr Bewusstsein für dieses Thema bei Behandlern und Forschern geschaffen und dadurch Betroffenen ein leichterer Zugang zum Hilfesystem ermöglicht werden Methoden Es erfolgte eine Literaturrecherche über PupMed/Medline sowie ein Abgleich mit Cochrane und Embase für die Begriffe „chemsex“, „sexualized drug use“ oder „slamming“ wobei 22 Arbeiten als relevant identifiziert wurden Ergebnisse Der Fokus der veröffentlichten Literatur zur Thematik liegt aktuell vor allem auf der Beschreibung somatischer Komorbiditäten. Es besteht ein deutlich erhöhtes Risiko für sexuell übertragbare Erkrankungen, wobei auch psychische Erkrankungen wie Depressionen, substanzinduzierte Psychosen und Suchterkrankungen bedeutende Folgen von Chemsex zu sein scheinen. Ein individualisierter und spezialisierter Therapieansatz ist zum aktuellen Zeitpunkt noch nicht etabliert Diskussion Die Komplexität der Thematik zwischen Psychiatrie und Somatik erscheint durch die aktuelle Datenlage noch nicht ausreichend abgebildet. Aufgrund der wechselseitigen Beeinflussung der unterschiedlichen Komorbiditäten ist diese Patientenklientel bei fehlendem spezifischem Therapieangebot jedoch besonders gefährdet, weswegen weitere Forschung zu diesem Thema benötigt wird.